The rising incidence of multidrug-resistant Gram-negative bacterial (MDR-GNB) infections acquired in intensive care units has prompted a variety of patient-level infection control efforts. However, it is not known whether these measures are effective in reducing colonisation and infection. The purpose of this systematic review was to assess the efficacy of patient-level interventions for the prevention of colonisation with MDR-GNB and whether these interventions are associated with a reduction in the rate of infection due to MDR-GNB in the intensive care unit. Searches were conducted on PubMed, Cochrane, EMBASE and World of Science databases to identify comparative interventional studies on patient-level interventions implemented in the intensive care unit. Literature published in English, Spanish or French from January 1, 2000, until April 30, 2013, was searched. A total of 631 reports were found and we included and analysed 13 comparative studies that reported outcomes for an intervention compared with a control group. There were ten randomised and three observational interventional trials evaluating seven interventions. Overall, there was a reduction in colonisation (odds ratio [OR] 0.75; 95% confidence interval [CI] 0.66 to 0.85) and infection (OR 0.66; 95% CI 0.59 to 0.75) with MDR-GNB. This trend persisted after restricting pooled analysis to randomised controlled trials (pooled OR 0.66; 95% CI 0.57 to 0.76 and pooled OR 0.62; 95% CI 0.54 to 0.72, respectively). We identified a significant reduction in MDR-GNB colonisation and infection through the use of patient-level interventions. This effect was mostly accounted for by selective digestive decontamination. However, given the limitations of the analysed trials, adequately powered controlled studies are needed to further explore the effects of patient-level interventions on colonisation and infection with MDR-GNB.
ObritschM.D., FishD.N., MacLarenR., JungR.National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002.Antimicrob Agents Chemother2004; 48: 4606–4610.
2.
GaynesR., EdwardsJ.R.Overview of nosocomial infections caused by gram-negative bacilli.Clin Infect Dis2005; 41: 848–854.
3.
BoucherH.W., TalbotG.H., BradleyJ.S., EdwardsJ.E., GilbertD., RiceL.B.Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.Clin Infect Dis2009; 48: 1–12.
4.
SchwaberM.J., CarmeliY.Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis.J Antimicrob Chemother2007; 60: 913–920.
5.
GiskeC.G., MonnetD.L., CarsO., CarmeliY.Clinical and economic impact of common multidrug-resistant gram-negative bacilli.Antimicrob Agents Chemother2008; 52: 813–821.
6.
RebmannT., RosenbaumP.A.Preventing the transmission of multidrug-resistant Acinetobacter baumannii: an executive summary of the Association for Professionals in infection control and epidemiology's elimination guide.Am J Infect Control2011; 39: 439–441.
7.
SchwaberM.J., CarmeliY.Carbapenem-resistant Entero-bacteriaceae: a potential threat.JAMA2008; 300: 2911–2913.
8.
Bergogne-BerezinE., TownerK.J.Acinetobacter spp. as nosoco-mial pathogens: microbiological, clinical, and epidemiological features.Clin Microbiol Rev1996; 9: 148–165.
9.
NseirS., GraillesG., Soury-LavergneA., MinacoriF., AlvesI., DurocherA.Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care unit admission.Clin Microbiol Infect2010; 16: 902–908.
10.
JadadA.R., MooreR.A., CarrollD., JenkinsonC., ReynoldsD.J., GavaghanD.J.Assessing the quality of reports of randomized clinical trials: is blinding necessary?Control Clin Trials1996; 17: 1–12.
11.
MantelN., HaenszelW.Statistical aspects of the analysis of data from retrospective studies of disease.J Natl Cancer Inst1959; 22: 719–748.
12.
DerSimonianR., LairdN.Meta-analysis in clinical trials.Control Clin Trials1986; 7: 177–188.
13.
TimsitJ.F., SchwebelC., BouadmaL.Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial.JAMA, 2009.
14.
de JongeE., SchultzM.J., SpanjaardL., BossuytP.M.M., VroomM.B., DankertJ.Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial.Lancet2003; 362: 1011–1016.
15.
ForestierC., GuelonD., CluytensV., GillartT., SirotJ., De ChampsC.Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients.Crit Care2008; 12: R69.
16.
HeylandD.K., DodekP., MuscedereJ., DayA., CookD.Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia.Crit Care Med2008; 36: 737–744.
17.
OudhuisG.J., BergmansD.C., DormansT., ZwavelingJ.H., KesselsA., PrinsM.H.Probiotics versus antibiotic decontamination of the digestive tract: infection and mortality.Intensive Care Med2011; 37: 110–117.
18.
FourrierF., DuboisD., PronnierP., HerbecqP., LeroyO., DesmettreT.Effect of gingival and dental plaque antiseptic decontamination on nosocomial infections acquired in the intensive care unit: a double-blind placebo-controlled multicenter study.Crit Care Med2005; 33: 1728–1735.
19.
TopeliA., HarmanciA., CetinkayaY., AkdenizS., UnalS.Comparison of the effect of closed versus open endotracheal suction systems on the development of ventilator-associated pneumonia.J Hosp Infect2004; 58: 14–19.
20.
MelsenW.G., de SmetAMGA, KluytmansJAJW, BontenM.J.M.Selective decontamination of the oral and digestive tract in surgical versus non-surgical patients in intensive care in a cluster-randomized trial.Br J Surg2012; 99: 232–237.
21.
de SmetAMGA, KluytmansJAJW, BlokH.E.M., MasciniE.M., BenusR.F.J., BernardsA.T.Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study.Lancet Infect Dis2011; 11: 372–380.
22.
de SmetAMGA, KluytmansJAJW, CooperB.S., MasciniE.M., BenusR.F.J., van der WerfT.S.Decontamination of the digestive tract and oropharynx in ICU patients.N Engl J Med2009; 360: 20–31.
23.
Saidel-OdesL., PolachekH., PeledN., RiesenbergK., SchlaefferF., TrabelsiY.A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenem-resistant Klebsiella pneumoniae carriage.Infect Control Hosp Epidemiol2012; 33: 14–19.
24.
WarrenD.K., HillH.A., MerzL.R., KollefM.H., HaydenM.K., FraserV.J.Cycling empirical antimicrobial agents to prevent emergence of antimicrobial-resistant Gram-negative bacteria among intensive care unit patients.Crit Care Med2004; 32: 2450–2456.
25.
MartinezJ.A., NicolasJ.M., MarcoF., HorcajadaJ.P., Garcia-SegarraG., TrillaA.Comparison of antimicrobial cycling and mixing strategies in two medical intensive care units.Crit Care Med2006; 34: 329–336.
26.
FranceticI., KalenicS., HuicM., MercepI., Makar-AuspergerK., LikicR.Impact of aminoglycoside cycling in six tertiary intensive care units: prospective longitudinal interventional study.Croat Med J2008; 49: 207–214.
27.
BesselinkM.G.H., van SantvoortH.C., BuskensE., BoermeesterM.A., van GoorH., TimmermanH.M.[Probiotic prophylaxis in patients with predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial].Ned Tijdschr Geneeskd2008; 152: 685–696.
28.
FranceticI., KalenicS., HuicM., MercepI., Makar-AuspergerK., LikicR.Impact of aminoglycoside cycling in six tertiary intensive care units: prospective longitudinal interventional study.Croat Med J2008; 49: 207–214.
29.
ArvanitiK., LathyrisD., Clouva-MolyvdasP., HaidichA.B., MouloudiE., SynnefakiE.Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.Crit Care Med2012; 40: 420–429.
30.
SiemposI.I., NtaidouT.K., FalagasM.E.Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials.Crit Care Med2010; 38: 954–962.
31.
SchultzM.J., HaasL.E.Antibiotics or probiotics as preventive measures against ventilator-associated pneumonia: a literature review.Crit Care2011; 15: R18.
32.
BesselinkM.G.H., van SantvoortH.C., BuskensE., BoermeesterM.A., van GoorH., TimmermanH.M.Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial.Lancet2008; 371: 651–659.
33.
LiberatiA., D'AmicoR., PifferiS., TorriV., BrazziL., ParmelliE.Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care.Cochrane Database Syst Rev2009; n/a: CD000022.
34.
SilvestriL., van SaeneH.K.F., MilaneseM., GregoriD., GulloA.Selective decontamination of the digestive tract reduces bacterial bloodstream infection and mortality in critically ill patients. Systematic review of randomized, controlled trials.J Hosp Infect2007; 65: 187–203.
35.
DanemanN., SarwarS., FowlerR.A., CuthbertsonB.H.Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis.Lancet Infect Dis2013; 13: 328–341.
36.
HuangS.S., SeptimusE., KleinmanK., MoodyJ., HickokJ., AveryT.R.Targeted versus universal decolonization to prevent ICU infection.N Engl J Med2013; 368: 2255–2265.
37.
PaulM., Benuri-SilbigerI., Soares-WeiserK., LeiboviciL.Beta lac-tam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials.BMJ2004; 328: 668.
